
Company valuation, historical trends, and peer comparisons.
According to Protalix BioTherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 189.26M. This represents a change of 23.34% compared to the average of 153.44M of the last 4 quarters.
The mean historical Enterprise Value of Protalix BioTherapeutics, Inc. over the last ten years is 134.81M. The current 189.26M Enterprise Value has changed 40.39% with respect to the historical average. Over the past ten years (40 quarters), PLX's Enterprise Value was at its highest in in the March 2017 quarter at 238.77M. The Enterprise Value was at its lowest in in the December 2021 quarter at 32.14M.
Average
134.81M
Median
106.96M
Minimum
31.20M
Maximum
465.41M
Discovering the peaks and valleys of Protalix BioTherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 402.91%
Maximum Annual Enterprise Value = 465.41M
Minimum Annual Increase = -81.16%
Minimum Annual Enterprise Value = 31.20M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 135.02M | 10.56% |
| 2024 | 122.12M | -1.69% |
| 2023 | 124.23M | 50.09% |
| 2022 | 82.77M | 165.32% |
| 2021 | 31.20M | -79.47% |
| 2020 | 151.94M | 65.51% |
| 2019 | 91.80M | 64.17% |
| 2018 | 55.92M | -36.24% |
| 2017 | 87.70M | -81.16% |
| 2016 | 465.41M | 402.91% |
The current Enterprise Value of Protalix BioTherapeutics, Inc. (PLX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
127.13M
5-year avg
99.07M
10-year avg
134.81M
Protalix BioTherapeutics, Inc.’s Enterprise Value is greater than Polaryx Therapeutics, Inc. Common Stock (76.44M), less than Ultragenyx Pharmaceutical Inc. (2.65B), less than Pharming Group N.V. (819.90M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 76.44M | $87.98M | |
| 2.65B | $1.57B | |
| 819.90M | $886.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protalix BioTherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Protalix BioTherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Protalix BioTherapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Protalix BioTherapeutics, Inc. (PLX)?
What is the 3-year average Enterprise Value for Protalix BioTherapeutics, Inc. (PLX)?
What is the 5-year average Enterprise Value for Protalix BioTherapeutics, Inc. (PLX)?
How does the current Enterprise Value for Protalix BioTherapeutics, Inc. (PLX) compare to its historical average?